Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
February 28, 2024 16:29 ET
|
Societal CDMO, Inc.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...
Berkshire Sterile Manufacturing Announces the Launch of Its Webinar Series, Perfecting Fill Finish
February 28, 2024 13:00 ET
|
Berkshire Sterile Manufacturing
Lee, MA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO and subsidiary of Sharp, will launch a webinar series, Perfecting Fill...
Europe Nucleic Acid Therapeutics CDMO Market Analysis and Forecasts, 2023-2033: Increasing FDA or European Medicines Agency Approvals, Pharmaceutical Firms Becoming More Outsourcing-Oriented
February 28, 2024 09:01 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Europe Nucleic Acid Therapeutics CDMO Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe...
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
February 26, 2024 11:00 ET
|
Alira Health
Framingham, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global life sciences advisory and clinical research firm, announced the release of the 2024 Global Medtech Contract Manufacturing...
Global Advanced Therapy Medicinal Products CDMO Market Analysis Report 2024-2030: : Increasing Investment and Clinical Trial Expenditure Driving Demand, Oncology Dominance and Emerging Treatment Areas
February 22, 2024 06:42 ET
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report by Product (Gene Therapy, Cell Therapy), Phase,...
Global Biologics Contract Manufacturing Research Report 2022-2023 and 2023-2035: Biologics CMO Made Considerable Investments to Expand Facilities, With Some CMOs Re-evaluating Capacity Investments
February 20, 2024 04:01 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of...
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
February 01, 2024 07:00 ET
|
Societal CDMO, Inc.
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing...
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
February 01, 2024 04:30 ET
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Feb. 01, 2024 (GLOBE NEWSWIRE) -- To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global...
India Contract Manufacturing Market Poised for Remarkable Growth, Size Expected to Reach USD 38.92 Billion by 2028
January 30, 2024 19:54 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Contract Manufacturing In India Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Ophthalmic Drugs Contract Manufacturing Market Analysis 2023-2033: Cost Efficiencies Provided by Specialized Manufacturing Partners Driving the Industry
January 26, 2024 11:17 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The ophthalmic drugs...